We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Ultrasound and Microtubules Successful at Penetrating the Blood-Brain Barrier

By LabMedica International staff writers
Posted on 01 Apr 2012
One of the most complex elements of treating brain disorders is the blood brain barrier (BBB), a blockade of cells that prevent both destructive toxins and useful pharmaceutical agents from getting to the body’s control center. More...
However, a technique that uses a magnetic resonance imaging (MRI) scanner to guide the use of microbubbles and focused ultrasound to help therapeutic drugs enter the brain, which may open new treatment avenues for devastating disorders such as Alzheimer’s disease and brain cancers.

“It’s getting close to the point where this could be done safely in humans,” said author of the study, Dr. Meaghan O'Reilly, a research engineer/physicist from Sunnybrook Research Institute (Toronto, Ontario, Canada), “there is a push towards applications.” The study’s findings were published March 13, 2012, in the journal JoVE.

The current approach of disrupting the BBB is by using osmotic agents such as mannitol, which draw the water out of the cells that form the barrier, causing the gaps between them to get larger. Unfortunately, this technique opens large areas of the barrier, leaving the brain exposed to toxins.

The advantage of the microbubble technique is that it can be used on a very small area of the BBB. The microbubbles, comprised of lipids and gas, are injected into the blood stream. When focused ultrasound is applied, the bubbles expand and contract. It is thought that the force of the movement in the bubbles causes the cells that form the BBB to temporarily separate, which allows agents to reach the brain.

“Microbubble technology has been around for years, though its applications have mostly been as contrast agents for diagnostic ultrasound,” said JoVE editorial director, Dr. Beth Hovey. “This newer approach, using ultrasound to help the bubbles permeablize the blood brain barrier, will hopefully allow for better treatment of diseases within the brain.”

In this method, Dr. O'Reilly and her colleagues use the MRI machine to ensure that the barrier opens, and they can also time how long it takes for it to close, which will be important for when the technique is used on patients. “The ability of focused ultrasound combined with microbubbles to disrupt the blood brain barrier has been known for over a decade. However, because the actual technique can be challenging--there are critical steps involved--the [study] fills a gap in the literature that is a major hindrance to people getting into the field,” she said.

Related Links:

Sunnybrook Research Institute



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HPV Molecular Test
BD Onclarity HPV Assay
New
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.